Time‐action profile of the soluble, fatty acid acylated, long‐acting insulin analogue NN304

Abstract

Injection of NN304 at different doses resulted in an increase in total NN304 concentration in a linear dose-response effect and a more even metabolic effect than NPH-insulin. However, we found no clear dose-response in its metabolic effect.